Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico.

Then, we stratify for decades since viral diagnoses and observed an increasing trend of coinfection where we observed a 2.5% (95% CI: 1.79%-3.53%) prevalence in diagnoses years after 2010, followed by 0.46% (95% CI: 0.21%-1.0%) for the years of 2000–2010 and a 0.23% (95% CI: 0.08%-0.68%) for years prior to 2000 ( Fig 2 ).

also in 63,971 other papers